Ammar Chaudhry

机构：AstraZeneca (Netherlands), AstraZeneca (Japan) · ORCID：0000-0002-2126-0587

发表论文 85 篇 · 总被引 1389 次 · h-index 17

代表论文

• Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial (2024 · Nature Medicine · 被引 321)
• CNS Efficacy of Osimertinib With or Without Chemotherapy in Epidermal Growth Factor Receptor–Mutated Advanced Non–Small-Cell Lung Cancer (2023 · Journal of Clinical Oncology · 被引 136)
• PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial (2024 · Nature Medicine · 被引 129)
• Response-adapted anti-PD-1–based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE (2022 · Blood · 被引 121)
• Phase 1 study of PSCA-targeted chimeric antigen receptor (CAR) T cell therapy for metastatic castration-resistant prostate cancer (mCRPC). (2022 · Journal of Clinical Oncology · 被引 19)
• Diagnostic Utility of Radiomics in Thyroid and Head and Neck Cancers (2021 · Frontiers in Oncology · 被引 17)